FDA chief will testify at first meningitis hearing

(AP)—House lawmakers investigating a nationwide outbreak of deadly meningitis are asking the head of the Food and Drug Administration to testify at the first congressional hearing on the issue next week.

The Energy & Commerce Committee says FDA Commissioner Dr. Margaret Hamburg will appear before the committee on Nov. 14.

More than 400 people have been sickened by contaminated steroid shots distributed by New England Compounding Center, according to the Centers for Disease Control and Prevention. Twenty nine people have died.

Committee staffers say they have also invited Barry Cadden, co-founder of the compounding center, the specialty pharmacy linked to the . The committee has also invited James Coffey, director of the Massachusetts Board of Registration in Pharmacy. Staffers say they are awaiting replies from Cadden and Coffey.


Explore further

2nd firm agrees to temporary shutdown in outbreak

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: FDA chief will testify at first meningitis hearing (2012, November 5) retrieved 15 September 2019 from https://medicalxpress.com/news/2012-11-fda-chief-testify-meningitis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more